Now, Novartis hopes to be able to share the data with regulatory authorities in 2025, including the US FDA, in the hope of ...

Pfizer's decision could stem from the fairly dismal performance of the only gene therapy for haemophilia A currently on the ...

Research projects that generative AI could boost the pharma and medical-product industries' annual revenues by up to $110 ...

Daiichi Sankyo has claimed approval in Japan, its home market, for TROP2-targeting antibody-drug conjugate (ADC) datopotamab ...

Opdivo Qvantig (nivolumab and hyaluronidase) has been approved for use across almost all of Opdivo's lengthy list of ...

Those key challenges impacting the care of respiratory diseases include delays in diagnosis due to the intermittent nature of ...

It was the day we’d all been waiting for. Rachel Reeves’ Autumn Budget felt like it had been on the horizon for a while. And it was great to see a commitment to the NHS, with an extra £22.6 ...

Another clinical trial has found that SIGA Technologies' antiviral drug tecovirimat is ineffective as a treatment for mpox, prompting the investigators to stop patient recruitment. The study by ...

Prominent podcaster Steven Bartlett has been accused of allowing misleading health information to be shared on his Diary of a CEO stream, which has millions of subscribers. A BBC investigation ...

Four years after buying exclusive US rights to GAIA's digital therapeutic to help people with depression, Swedish drugmaker Orexo has terminated the deal. Deprexis is an online cognitive ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

A new study has confirmed that the rate of colorectal cancer is rising in younger adults around the world, with England among the countries seeing the highest increase. The paper in The Lancet ...